期刊文献+

上调miR-200a表达对人肝癌细胞MHCC97中边缘群细胞干细胞特性的影响 被引量:2

Effects of miR-200a up-regulation on the characteristics of stem cells of side population in hepatocellular carcinoma cell line MHCC97
下载PDF
导出
摘要 目的:探讨转染miR-200a mimics对人肝癌细胞系MHCC97中边缘群细胞(SP)干细胞特性的影响。方法:利用流式细胞技术从MHCC97细胞中分离出SP细胞。转染组为应用脂质体介导转染miR-200a mimics的SP细胞,对照组为未接受转染的SP细胞。采用实时荧光定量RT-PCR检测两组SP细胞miR-200a的表达情况。四甲基偶氮唑盐(MTT)和软琼脂克隆形成实验检测细胞增殖情况。Transwell小室检测细胞迁移能力。裸鼠成瘤实验检测细胞体外成瘤能力。结果:转染miR-200a mimics可明显上调SP细胞miR-200a的表达。MTT结果显示转染组SP细胞的增殖能力明显低于对照组(P<0.05),转染组软琼脂中克隆形成率(24.70±5.54)%明显低于对照组(51.63±7.11)%(P<0.05)。Transwell实验显示转染组细胞穿膜数为(18.52±4.27)个,明显少于对照组(63.34±7.41)个(P<0.05)。裸鼠成瘤实验中转染组成瘤数(1/8)也低于对照组(8/8)(P<0.05)。结论:上调人肝癌细胞系MHCC97中SP细胞miR-200a的表达,能够抑制SP细胞的增殖和迁移,降低体外成瘤能力,即抑制SP细胞的干细胞特性。 Objective:To investigatet the effects of miR-200a up-regulation on the characteristics of stem cells of side population in hepatocellular carcinoma cell line MHCC97. Methods:SP(side population)cells were isolated by fluorescence activated cell sorting( FACS)from MHCC97 cell line of human hepatocellular carcinoma. The miR-200a mimics was transfected into SP cells by liposome. The expression levels of miR-200a in SP cell pre- and post-tranfection was measured by reverse transcription polymerase chain reaction( RT-PCR ). MTT method and Soft agar cloning method was used to evalute the capability of cell proliferation. The invasion and migration capability of cells were evaluated by using transwell chamber model. Tumor cell implantation experiment was done to test the tu-morigenicity. Results:The expression of miR-200a in SP cell was obviously up-regulated transfection of post miR-200a mimics. MTT assay showed that the cell proliferation ability of SP in transfected group was obviously lower than control group(without transfection)(P〈0. 05). The rate of clone formation was(24. 70±5. 54)% in trans-fected group and it was(51. 63 ± 7. 11)% in control group(P〈0. 05). Transwell chamber assay demonstrated the cell penetrating number was 18. 52 &#177; 4. 27 in transfected group and it was 63.34 ±7.41 in control group(P〈0. 05). The number of tumors that formed in transfected group(1/8)was significantly lower than in the control group (8/8)(P〈0. 05). Conclusion:Up-regulation of the miR-200a expression in SP cells of MHCC97 cell line would inhibit their ability of proliferation and migration,decrease their tumor formation ability in vitro,which is indicate the inhibition of the stem cell characteristics of SP cells.
出处 《现代肿瘤医学》 CAS 2015年第17期2410-2413,共4页 Journal of Modern Oncology
基金 甘肃省科技支撑计划-社会发展类基金项目(编号:1104FKCA154)
关键词 肝癌 边缘群 肿瘤干细胞 microRNA liver cancer side population cancer stem cell microRNA
  • 相关文献

参考文献17

  • 1Zheng S,Xin L,Liang A,et al. Cancer stem cell hypothesis:a brief summary and two proposals[ J ]. Cytotechnology ,2013,65 (4):505 -512.
  • 2Harris MA, Yang H, Low BE, et al. Cancer stem cells are enriched in the side population cells in a mouse model of glioma[ J]. Cancer Res,2008,68 ( 24 ) : 10051 - 10059.
  • 3申发娟,苏娟,张庆瑜,康春生,周磊,王涛.上调miR-200a、miR-141表达对胃腺癌细胞生长的体外研究[J].天津医药,2013,41(6):517-519. 被引量:7
  • 4苏娟,张庆瑜,康春生,张安玲,王涛,张洁.miR-200a通过β-catenin/TCF-4信号通路抑制胃癌细胞系生长侵袭能力的体外研究[J].中国肿瘤临床,2012,29(2):65-69. 被引量:9
  • 5Allegra A,Alonci A,Penna G, et al. The cancer stem cell hypothe- sis : a guide to potential molecular targets [ J ]. Cancer Invest,2014, 32(9) :470-495.
  • 6Zheng D, Liao S, Zhu G, et al. Side population cells and progress in cancer stem cell research [ J ]. J Central South University,2014,39 (5) :525 -531.
  • 7Zhang Y, Song WJ, Zhang FQ, et al. Differentiation - inducing ac- tivity of hydroxycamptothecin on cancer stem - like ceils derived from bepatocellular carcinoma [ J ]. Dig Dis Sci,2011,56 (8) : 2473 - 2481.
  • 8Kizaki M. Differentiation -inducing therapy[ J]. Nihon Rinsho, 2012,70 ( Suppl 2 ) :207 - 210.
  • 9Coordes A, Zhifeng S, Sangvatanakul V, et al. Cancer stem cell phe- notypes and miRNA : Therapeutic targets in head and neck squa- mous cell carcinoma[ J]. HN0,2014,62(12) :867 -872.
  • 10Li A, Omura N, Hong SM, et al. Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR- 200a/ 200b in association with elevated circulating miR - 200a and miR - 200b levels [ J ]. Cancer Res ,2010,70 ( 13 ) :5226 - 5237.

二级参考文献20

  • 1Dykxhoorn DM, Ghowdhury D, Lieberman J. RNA interference and cancer: endogenous pathways and therapeutic approaches[J]. Adv Exp Med Biol, 2008, 615: 299-329.
  • 2Gregory PA, Bracken CP, Bert AG, et al. MicroRNAs as regulators of epithelial-mesenchymal transitionS. Cell Cycle, 2008, 7(20): 3112-3118.
  • 3Xia H, Ng SS, Jiang S, et al. miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion[J]. Biochem Biophys Res Commun, 2010, 391(1): 535-541.
  • 4Hu X, Schwarz JK, Lewis JS Jr, et al. A microRNA expression signature for cervical cancer prognosis[J]. Cancer Res, 2010, 70(4): 1441-1448.
  • 5Du Y, Xu Y, Ding L, et al. Down-regulation of miR-141 in gastric cancer and its involvement in cell growth[]]. J Gastroenterol, 2009, 44(6): 556-561.
  • 6Park SM, Gaur A.B, Lengyel E, et al. The miR-200 family determines the epithefial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2[J]. Genes Dev, 2008, 22(7): 894-907.
  • 7Adam L, Zhong M, Choi W, et al. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy[J]. Clin Cancer Res, 2009, 15(16): 5060-5072.
  • 8Tryndyak VP, Ross SA, Beland FA, et al. Down-regulation of the microRNAs miR-34a, mi_R-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet Molecular carcinogenesis[J]. Mol Carcinog, 2009, 48(6): 479-487.
  • 9Cardiff RD. Epithelial to mesenchymal transition tumors: fallacious or snail' s pace[J] ? Clin Cancer Res, 2005, 11 (24) : 8534-8553.
  • 10Thompson EW, Newgreen DF, Tarin D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition[J]? Cancer Res, 2005, 65(14): 5991-5995.

共引文献14

同被引文献61

  • 1Mitra A,Satelli A,Xia X,et al.Cell-surface Vimentin: a mislocalized protein for isolating csVimentin(+) CD133(-)novel stem-like hepatocellular carcinoma cells expressing EMT markers.Int J Cancer.2015;137(2):491-496.
  • 2Chen D,Zheng XF,Jiao XL,et al.Transcriptional repressor snail and metastasis in hepatocellular carcinoma.Hepatogastroenterology.2012;59(117):1359-1365.
  • 3Zheng LY,Zhou DX,Lu J, et al.Down-regulated expression of the protein- tyrosine phosphatase 1 B(PTPIB)is associated with aggressive clinicopathopathologic features and poor prognosis in hepatocellular carcinoma.Biochem Biophys Res Commun.2012:420(3):680-684.
  • 4Kojima K,Takata A,Vadnais C,et al.MicroRNAI22 is a key regulator of a-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma.Nat Commun.2011;2:338-338.
  • 5Bae JH,Park SH,Yang JH,et al.Stem cell-like gene expression signature identified in ionjzing radiation-treated cancer cells.Gene.2015;572(2):285-291.
  • 6Nio K,Yamashita T,Okada H,et al.Defeating EpCAM(+)liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.J Hepatol.2015:63(5):1164-1172.
  • 7Zhong C,Wu JD,Fang MM,et al.Ctinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis.Tumour Biol.2015;36(10):7623-7630.
  • 8Ding M,Li J,Yu Y,et al.Integrated analysis of miRNA,gene,and pathway regulatory networks in hepatic cancer stem cells.J Transl Med.2015:13:259.
  • 9Liu R,Shen Y,Nan K,et al.Association between expression of cancer stem cell markers and poor differentiation of hepatocellular carcinoma: a meta-analysis(PRISMA).Medicine(Baltimore).2015;94(31):e1306.
  • 10Zhu L,Zhang W,Wang J,et al.Evidence of CD90+CXCR4+ cells as circulating tumor stem cells in hepatocellular carcinoma.Tumour Biol.2015;36(7):5353-5360.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部